Larvol Delta - BioGaia-Pharma-announces-First-Patient-Enrolled-in-Phase-I-Clinical-Study-Evaluating-BGP014-in-mild-to-moderate-ulcerative-colitis-AUCH1

lactobacillus reuteri (BGP014) - BioGaia

https://news.cision.com/biogaia-pharma/r/biogaia-pharma-announces-first-patient-enrolled-in-phase-i-clinical-study-evaluating-bgp014-in-mild-,c3503744

Feb 10, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next